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The human multidrug resistance protein MRP1 (or ABCC1) is one of the most important members of the large ABC transporter family, in
terms of both its biological (tissue defense) and pharmacological functions. Many studies have investigated the function of MRP1, but structural
data remain scarce for this protein. We investigated the structure and dynamics of predicted transmembrane fragment 17 (TM17, from Ala1227 to
Ser1251), which contains a single Trp residue (W1246) involved in MRP1 substrate specificity and transport function. We synthesized TM17 and a
modified peptide in which Ala1227 was replaced by a charged Lys residue. Both peptides were readily solubilized in dodecylmaltoside (DM) or
dodecylphosphocholine (DPC) micelles, as membrane mimics. The interaction of these peptides with DM or DPC micelles was studied by steady-
state and time-resolved Trp fluorescence spectroscopy, including experiments in which Trp was quenched by acrylamide or by two brominated
analogs of DM. The secondary structure of these peptides was determined by circular dichroism. Overall, the results obtained indicated significant
structuring (∼50% α-helix) of TM17 in the presence of either DM or DPC micelles as compared to buffer. A main interfacial location of TM17 is
proposed, based on significant accessibility of Trp1246 to brominated alkyl chains of DM and/or acrylamide. The comparison of various
fluorescence parameters including λmax, lifetime distributions and Trp rotational mobility with those determined for model fluorescent
transmembrane helices in the same detergents is also consistent with the interfacial location of TM17. We therefore suggest that TM17 intrinsic
properties may be insufficient for its transmembrane insertion as proposed by the MRP1 consensus topological model. This insertion may also be
controlled by additional constraints such as interactions with other TM domains and its position in the protein sequence. The particular pattern of
behavior of this predicted transmembrane peptide may be the hallmark of a fragment involved in substrate transport.
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The human multidrug resistance-associated protein (MRP1)
was discovered in 1992 [1] and has since been identified as a
potential therapeutic target. MRP1 belongs to the large family of
ATP-binding cassette (ABC) transport proteins. It is the
representative of the ABCC branch of this family, 13 members
of which have been identified to date (http://www.nutrigene.4t.
com/humanabc.htm), and is also known as ABCC1. It is present
in most tissues and functions as an ATP-driven transporter that
expels various structurally unrelated molecules, including various
xenobiotics and amphiphilic organic anions such as glutathione
(GSH)-, glucuronate- and sulfate-conjugated compounds, from
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presence of GSH, possibly as a cotransporter [3,4]. MRP1
overexpression confers multidrug resistance on tumor cells and,
in some hematological cancers, such as acute leukemia, it seems
to be associated with a poor response to chemotherapy [5].
Furthermore, even in cells in which MRP1 is not overexpressed,
this protein may affect the pharmacokinetic properties of drugs
used for chemotherapy.
MRP1 is a large glycosylated integral membrane protein with
an Mr of 190,000 (1531 residues) which, according to protein
folding algorithms, contains three membrane-spanning domains
(MSD). The current topological model, which is supported by
epitope insertion [6,7] and glycosylation site mutation data [8],
consists of a specific N-terminal domain, MSD0, preceded by an
extracytosolic N-terminus and followed by a cytosolic loop (L0),
and two membrane domains MSD1 and MSD2, each followed
by a nucleotide-binding domain. Five transmembrane (TM)
helices are predicted for MSD0 and six each for MSD1 and
MSD2. However, experimental structural data remain scarce,
despite detailed studies of the function of this protein.
Site-directed mutagenesis experiments investigating the 17
predicted TM helices have demonstrated the functional
importance of fragment 17 (TM17), the most proximal helix
of the cytoplasmic MRP1 C-terminus [9,10]. In particular,
mutations in which Trp1246 was replaced by Cys, Ala, Phe, or
Tyr abolished the transport of estradiol 17-(β-D-glucuronide),
an endogenous estradiol metabolite formed in the liver and
excreted into bile, and prevented the drug resistance mediated
by MRP1 [10]. In addition, W1246 is conserved among the
various homologs of MRP1 and it has been suggested that this
residue forms a ring of functional importance with other
aromatic residues (W553, F594, W1198 and Y1243), based on
molecular modeling of MSD1 and 2 [11].
We investigated the topological organization and dynamics
of TM17 in membrane mimetic systems, by means of Trp
fluorescence and circular dichroism. W1246 is the only Trp
residue in TM17, making therefore this fragment ideal for
fluorescence experiments. This strategy, involving studies of an
isolated TM fragment, was based on the notion that membrane
proteins folding includes an initial formation of independently
stable transmembrane helices before their association within the
membrane—known as the two-stage model [12]. This model
was recently refined to include an additional stage, in which
helix association leads to further folding events, such as specific
binding [13]. Initial events such as interfacial binding and
folding of a TM fragment have also been rationalized from a
thermodynamic viewpoint [14].
The TM17 fragment under study has the following amino-
acid sequence:
A1227GL VGL SVS Y1236SL QVT TY1243L
 NW1246L VRM S1251
where the residues are numbered according to their position in
the protein, with aromatic residues shown in bold. It
encompasses the TM17 sequence (G1228–V1248) predicted by
the MEMSAT algorithm (e.g. [10]), with additional C-termamino-acids (of which the charged Arg1249) critical for GSH-
dependent binding of substrates and leukotriene C4 (LTC4)
binding and transport [15,16]. Most of the experiments were
also performed with the fragment:
K1227GL VGL SVS YSL QVT TYL NWL
 VRM S1251
in which the N-terminal hydrophobic Ala was replaced by a
charged Lys residue.
As previously (also see discussion below), we selected two
of the most suitable detergents for membrane protein (or
peptide) studies – dodecylmaltoside (DM) and dodecylpho-
sphocholine (DPC) – to use their micelles as membrane mimics.
DM in particular was the detergent in which MRP1 was recently
purified close to homogeneity while retaining functional
activity [15]. We applied a recently described method for
topological studies, making use of previously synthesized
brominated analogs of DM [17]. The use of brominated
detergents makes it possible to detect Trp-detergent contacts
by fluorescence analysis, because bromine atoms quench Trp
residues with which they are in contact (or within a very short
distance) with high efficiency, via the so-called heavy atom
quenching mechanism [18,19].
The interaction of native and mutated TM17 fragments with
micelles of DM and DPC was characterized using various
fluorescence approaches. We analyzed the steady-state fluores-
cence spectra and decomposition of these spectra into their
elementary components, to estimate the polarity of the Trp
microenvironment. The depth-dependent fluorescence quench-
ing of Trp by 7,8-dibromododecylmaltoside (BrDM) or 10,11-
dibromoundecanoylmaltoside (BrUM) as brominated analogs
of DM, or by acrylamide as a soluble quencher, enabled us to
estimate the location of Trp in the micelle. Time-resolved
fluorescence intensity and fluorescence anisotropy data pro-
vided information concerning Trp rotamer distribution and
dynamics, respectively, in the subnanosecond and nanosecond
time ranges. Secondary structure was deduced by analyzing far-
UV CD spectra.
We also carried out steady-state and time-resolved fluores-
cence experiments for a set of fluorescent synthetic peptides in
DPC micelles: the peptides used were Lys-flanked polyLeu
sequences, which serve as models of transmembrane α-helices,
each containing a single Trp (referred to as Pn, with n referring
to the position of the Trp residue in the sequence). The results
were used as a reference, extending the results previously
obtained for these peptides in DM micelles [17].2. Materials and methods
2.1. Chemicals
DMwas obtained fromCalbiochem and its two brominated derivatives– 7,8-
dibromododecylmaltoside (BrDM) and 10,11-dibromoundecanoylmaltoside
(BrUM) – were synthesized by Insavalor (Villeurbanne, France), as previously
described [20,21]. DPC was obtained from Avanti Polar Lipids (AL, USA) or
from Anatrace (OH, USA). Stock solutions of these detergents were prepared in
Milli-Q water at concentrations of 20 and 200 mM. N-acetyltryptophanamide
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stock solution of 5 M acrylamide in water. Methanol, ethanol and DMSO were
obtained from Merck (Uvasol quality). Buffers were filtered through Millex-HA
filters (0.45 μM pore size; Millipore).
2.2. Peptides
The peptide AGL-VGL-SVS-YSL-QVT-TYL-NWL-VRM-S (Mw=2797)
(subsequently referred to as TM17), which encompasses the predicted
transmembrane fragment 17 of MRP1, and its N-terminal mutant A1227K
(called mTM17) (Mw=2853), were synthesized by Jerini (Berlin, Germany).
Note that the mutation was performed on the side opposite to that demonstrated
to be associated with substrate binding. These peptides were acetylated at the N-
terminus and amidated at the C-terminus. TM17 preparations were>80–85%
pure, whereas mTM17 preparations were 80–90% pure, as estimated by matrix-
assisted laser desorption ionization time-of-flight (MALDI/TOF) mass spectro-
metry. They were used as supplied.
The six synthetic model peptides – K2WL9AL9K2A (P3), K2CLWL7AL9-
K2A (P5), K2CL3WL5AL9K2A (P7), K2CL5WL3AL9K2A (P9), K2CL7WLAL9-
K2A (P11) and K2CL9WL9K2A (P13) – denoted Pn, with the index n indicating
the position of the Trp residue, were purchased from Research Genetics
(Huntsville, AL, USA), as previously described [17]. A new batch of P13 was
also obtained from Epytop (France). Stock solutions (2 mM) of model peptides
were made up in methanol.
2.3. MRP1 fragment solubilization assays and preparation of mixed
peptide-detergent micelles
Unlike Pn model peptides, TM17 was not soluble in methanol and was
therefore dissolved in DMSO to give a clear stock solution (1 mM). By contrast,
mTM17, which contains two positively charged residues instead of one in TM17
(Arg1249), was dissolved in methanol and stock solutions (1 mM) were therefore
made up in this solvent.
Concentrations were checked by comparison with absorption spectra in
these solvents. Each peptide contains one Trp and two Tyr residues, and the
molar absorption coefficient was taken as εmax=8400 M
−1 cm−1 at the
maximumwavelength (∼282 nm), using ε=5600M−1 cm−1 and 1400M−1 cm−1
for Trp and Tyr, respectively, at the maximum, as previously described [22]. This
may have resulted in a slight overestimation of concentrations (∼10%), as the
molar absorption coefficients of both Tyr and Trp may be slightly higher in
alcoholic solutions [23]. We checked, with mTM17, that maximal absorbance in
DMSO was similar to that in methanol.
Unless otherwise stated, the mixed peptide-detergent micelles were
prepared by adding an aliquot of the peptide stock solution to the aqueous
buffer (usually 10 mM potassium phosphate buffer, pH 7.5, at 20 °C)
supplemented with 4 mM detergent (DM, DPC or mixtures of DM with one
of its brominated analogs), with a dilution factor of at least 100 and constant
stirring. In these conditions, most of DM and its analogs are in their micellar
form, due to their low critical micellar concentration (cmc) (170–180 μM,
220 μM and 320 μM respectively for DM, BrDM and BrUM [21,24]). For
DPC, 2.9 mM (out of 4 mM) detergent is micellar (as the cmc of
DPC=1.1 mM [25]).
Note: the absorption of brominated detergents contributed to the absorption
in the 250–270 nm range of peptides in micelles (together with that resulting
from slight diffusion from the micelles) as an absorption band centered on a
wavelength close to 200 nm was observed (as previously described for other
brominated compounds [26]).
2.4. Small unilamellar vesicle preparation and peptide incorporation
SUV were prepared from egg PC and egg PS (Avanti Polar Lipids,
Alabaster, Al). Briefly, the chloroformic solution of phospholipids was
evaporated under a stream of nitrogen and dried under vacuum for 2–3 h.
The dry film was rehydrated in 10 mM potassium phosphate buffer, pH 7.5,
vortexed and sonicated (Vibrator Cell, Sonics, Cn) with the microtip. The
peptides were either added in buffer to preformed SUV or co-evaporated with
phospholipids.2.5. Absorption measurements
Absorption spectra were recorded on an HP8453 diode array spectro-
photometer, with a thermostatically controlled sample holder (20 °C). The
sample was continuously stirred in a 1-cm path length cuvette.
2.6. Steady-state fluorescence measurements
Fluorescence data were obtained on a Spex Fluorolog spectrofluorometer. The
temperature in the cuvette was controlled with a thermostat and the sample was
continuously stirred. We used standard quartz cuvettes (1×1 cm). Excitation spectra
were corrected for the spectrum of the lamp and both excitation and emission
spectra were corrected for fluctuations in lamp intensity (usually very small, <1%).
2.7. Spectral decomposition of steady-state fluorescence emission
spectra
The steady-state fluorescence spectra were analyzed using up to three four-
parameter log-normal functions (a skewed Gaussian equation) of the following
form [27,28]:
IðmÞ ¼ Imexpfðln2=ln2qÞ  ln2½ða mÞ=ða mmÞgðat m < aÞ
IðmÞ ¼ 0 ðat m < aÞ
here, Im= I(νm) is the maximal fluorescence intensity; νm is the wavenumber of
the band maximum (peak); ρ= (νm − ν−)/(ν+−νm) is the band asymmetry
parameter; ν+ and ν− are the wavenumber positions of left and right half-
maximal amplitudes; a is the function-limiting point: a=νm+ FWHM ρ/(ρ
2−1);
the full width at half-maximum FWHM=ν+−ν.
We fitted a linear combination of this analytical model to the emission
spectra by the least squares regression method (KaleidaGraph, Synergy
Software, PA). A good fit was ensured by minimization of the squared residuals.
2.8. Fluorescence quenching by brominated detergents
Fluorescence quenching experiments of MRP1 fragments in mixed micelles of
DM with a brominated analog (BrDM or BrUM) were performed essentially as
previously described [17]. Data were analyzed with a lattice model of quenching
([29,30], see also [31]). This model was originally designed to describe the
quenching of membrane fluorophores (e.g. protein Trp) by spin-labeled or
brominated phospholipids. It considers two populations of fluorophores: one
completely inaccessible to the quencher and responsible for the residual
fluorescence Fmin (e.g. Trp embedded in a protein), and one in which each
fluorophore has n neighbors (phospholipids) and for which fluorescence is
completely quenched if one (or more) of these sites is (are) occupied by a modified
phospholipid (corresponding to a quenching efficiency of 100% upon contact). It is
thought that phospholipids do not change position during the lifetime of the
fluorophore. If X is the molar fraction of quenchers in the membrane, then (1−X)n is
the probability that none of the n sites is occupied by a quencher. The fluorescence
ratio is therefore given by: F/F0=(1−Fmin /F0)(1−X)n+Fmin /F0. In a micellar
environment, unlike in lipid bilayers, the “lattice parameter” n is not expected to
give an exact determination of quenchers around Trp because, in addition to static
quenching, some dynamic quenching occurs [17,21], and because the transverse
inaccessibility of Trp is not taken into account directly in the model. This parameter
n is, however, correlated to the accessibility of this residue to brominated alkyl
chains. We used the set of six model peptides Pn with Trp at various positions in the
sequence (positions 3, 5, 7, 9 and 13 in the 25-amino acid sequence) to establish
calibration curves for n [17].We used these data as a reference, for comparisonwith
the results obtained.
2.9. Fluorescence quenching by acrylamide
Fluorescence was quenched with acrylamide essentially as previously
described [32]. Peptide quenching was analyzed using the classical Stern–
Volmer equation (see, for reviews, [33,34]):
F0=F ¼ 1þ KSV½Q
Fig. 1. Fluorescence emission spectra of TM17 and mTM17 in various media.
(A) Normalized emission spectra of TM17 (5 μM) in 10 mM potassium
phosphate buffer, pH 7.5, supplemented with 4 mM DM (continuous line) or
4 mM DPC (dashed line and hatched area) at 20 °C. λex was set at 280 nm. Slit
widths were 1.25 mm (bandwidths ∼5 nm) for both excitation and emission.
Spectra were recorded after a short period of equilibration (2–3 min) and the
readings for background spectra (detergent in buffer) were subtracted. The
vertical dashed line indicates λmax in DPC. (B) Normalized emission spectra of
mTM17 (5 μM) in the presence of 4 mM DM (same buffer as above)
(continuous line) or 4 mM DPC (dashed line and hatched area) or mTM17
(10 μM) in methanol (dotted line), at 20 °C. Other conditions were as stated
above.
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quencher, respectively, Ksv is the Stern–Volmer quenching constant and [Q] is
the quencher concentration. Ksv is related to the bimolecular quenching constant
kq by the following formula:
KSV ¼ kqs0
where τ0 is the lifetime, in the absence of quencher, of the fluorophore.
For NATA, taken as a reference, we used the nonlinear Stern–Volmer
equation:
F0=F ¼ ð1þ KSV½QÞexpV ½Q
where V can be considered as a sphere of action around the fluorophore in which
the presence of a quencher molecule results in instantaneous (static) quenching.
2.10. Time-resolved fluorescence measurements
Fluorescence intensity and anisotropy decays were measured by the time-
correlated single-photon counting technique from the polarized Ivv(t) and Ivh(t)
components. Most experiments were performed as previously described [35]
using the synchrotron radiation machine Super-ACO (Anneau de Collision
d'Orsay). Experiments with mTM17 were carried out similarly, except that a
light-emitting diode (PLS 295, serial number PLS-8-2-237 from Picoquant,
Berlin-Adlershof, Germany) (maximal emission at 298 nm) was used as an
excitation source and that a Hamamatsu photomultiplier (model R3235-01) was
used for detection. As previously, fluorescence intensity I(t) and anisotropy
decays A(t) were analyzed as sums of 150 or 100 exponential terms,
respectively, by the maximum entropy method (MEM) [36] according to the
following equations:
IðtÞ ¼
X
aiexpðt=siÞ
where αi is the normalized amplitude and τ the lifetime of intensity decay, and
AðtÞ ¼
X
biexpðt=hiÞ
where βi is the anisotropy and θi the rotational correlation time of anisotropy
decay. In this second analysis, we assume that each lifetime τi is associated with
all rotational correlation times θi.
We recall that MEM does not impose any particular number of significant
parameters for the decay. The Skilling–Jaynes entropy S is subjected to a χ2
constraint [37], to ensure that the recovered distribution was consistent with the
data.
2.11. Circular dichroism
Far UV circular dichroism spectra were recorded on a Jobin Yvon CD6
spectrodichrograph calibrated with ammonium d-10 camphorsulfonate. Mea-
surements were made at 20 °C, using 0.1 cm and 0.01 cm path length quartz
cuvettes (Hellma) for 25 μM peptide in buffer, with or without 4 mM
detergent, and 100 μM peptide in methanol, respectively. Spectra were
recorded in the 185 to 260 nm wavelength range with 0.5 nm wavelength
increments, 2 s integration time and 2 nm spectral bandwidth. Spectra were
averaged over four scans and corrected for background. Unsmoothed spectra
are presented. The α-helical content of the peptides was initially estimated as
for the model peptides [17] from the molar ellipticity value at 222 nm,
[θ]222nm, taking into account an helix length-dependent factor according to
[38]. Secondary structure was analyzed further with CDPro software (http://
www.lamar.colostate.edu/∼sreeram/CDPro) [39], which includes three differ-
ent methods for analyzing protein CD spectra (CONTIN/LL, CDSSTR and
SELCON3- [39,40]) and two reference protein sets, SDP42 (42 proteins) and
SMP50 (50 proteins including 13 membrane proteins). CONTIN/LL and
CDSSTR gave the most reliable analysis, as shown by the NRMSD
(normalized root mean square deviation) and comparison of the plots of
calculated and experimental spectra. We therefore used these two analyses to
obtain a consensus estimate of secondary structure.2.12. Calculation of the theoretical micellar rotational correlation
time
Theoretical θ values were estimated as previously, assuming spherical
micelles (so that θ=ηV/RT) and without taking into account micelle hydration.
With n, the aggregation number of the micelles of 55 and 125 (±10%)
respectively for DPC and DM, we obtained θ=7.4 ns for DPC and θ=21 ns for
DM micelles, at 20 °C [41].
3. Results
3.1. Steady-state fluorescence spectra of TM17 and mTM17 in
DM and DPC
Fig. 1A shows the fluorescence emission spectrum of the
TM17 fragment diluted in an excess of DM or DPC micelles in
10 mM potassium phosphate buffer. In these conditions, TM17
readily interacts with the detergent micelles resulting in a
fluorescence signal stable with time and with no significant
Fig. 2. Decomposition of mTM17 steady-state fluorescence spectra in various
media into log-normal Gaussian components. Comparison with the model
peptide P7 in DPC. mTM17 in DM (A), DPC (B) and methanol (C); P7 in DPC
(D). Normalized raw spectra (closed circles) are from Figs. 1 and 3, presented
with a wavenumber scale (lower scale). (Dashed lines), elementary Gaussian
components, obtained as described in Materials and methods; (continuous line),
spectra reconstituted from their components.
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detergents were almost entirely superimposable, indicating
that the Trp residue was located in environments of similar
average polarity in the two detergents. The emission maximum,
λmax, occurs at a value of 332 nm (Fig. 1A). This value indicates
that the Trp is partially shielded from the bulk solvent (for
NATA, a model for an exposed Trp, λmax=353 nm). However,
this value is slightly greater than the λmax previously obtained
for the single tryptophan-containing transmembrane model
peptides P3, P5 and P7 in each detergent – ∼327 nm in DM
[17] and∼329 nm in DPC (see below) – suggesting that the Trp
microenvironment is slightly more polar in TM17. In DMSO,
the solvent in which the TM17 stock solution was prepared,
λmax was 338 nm, characteristic of a Trp residue fully exposed
to this solvent, as expected (data not shown).
The emission spectrum of the N-terminal mutant mTM17 in
4 mM DM (Fig. 1B) was rather similar to that of TM17 in DM
(with λmax at 332 nm). By contrast, when mTM17 was diluted in
DPC, its emission spectrum displayed a slight red shift, with
λmax=335 nm, suggesting a slightly more polar Trp environ-
ment. In methanol, the solvent for mTM17 stock solution, λmax
for mTM17was 337 nm, as previously reported for the Pnmodel
peptides, characteristic of a Trp exposed to this solvent.
These spectra were analyzed further by decomposition into
their elemental components, using log-normal Gaussian dis-
tributions. This formalism suitable for fluorescence spectro-
scopy [28] originates from that developed for absorption
spectroscopy [42]. This decomposition is illustrated for
mTM17 in Fig. 2 and the parameters of the log-normal Gaussian
curves are shown in Table 1 for both TM17 and mTM17. In pure
solvents (methanol (Fig. 2C) or DMSO), a single main Gaussian
curve accounted for Trp fluorescence, as expected for a single
Trp in a homogeneous environment. In addition, a minor
Gaussian, centered at ∼305 nm, indicated a slight contribution,
to the whole fluorescence, of the two Tyr residues (Y1236 and
Y1243). In the presence of DM or DPC, and for both peptides,
the spectral decomposition yielded two well separated compo-
nents for Trp fluorescence (Fig. 2A and 2B). For TM17, the low-
polarity component (at 314–319 nm) and the higher polarity
component (at 347–349 nm) were about equally weighted. For
mTM17, both components were slightly red-shifted and the
lower polarity component was dominant. Small differences were
also observed as a function of the detergent used. These data
indicate that, in the bound peptide, Trp may experience exposure
to environments of various polarities. In addition, Tyr contribu-
tion was slightly quenched in solvents as compared to detergent
micelles. This suggests that Tyr–Trp (intramolecular) Förster
resonance energy transfer occurs in these solvents to a higher
extent than for detergent-bound peptides.
3.2. Steady-state fluorescence spectra of model peptides P3 to
P13 in DPC
For reference, we recorded the emission spectra in DPC of all
the single tryptophan-containing Pn model peptides (P3 to P13),
as previously done in DM [17]. In DM, Trp was found to be
located at various depths in the micelle, from the polarheadgroup region, to the center of the micelle core depending
on its position in the model peptide. The normalized spectra in
DPC (Fig. 3) clearly illustrate the shift of the raw spectrum and
of the resulting λmax in response to Trp location in the micelle.
The λmax values (Table 2) were very similar for P3, P5 and P7
(329 nm), and then decreased from P7 to P13. This variation
with Trp position is similar to that previously observed in DM
[17] (as also reported in Table 2), except that the λmax value was
slightly higher in the plateau region in DPC, indicating a
slightly higher polarity.
We also analyzed the steady-state fluorescence spectra of the
Pn model peptides in DPC by log-normal Gaussian decom-
position (Fig. 2D, for P7 as an example and Table 2). Here
again, two components, with λmax corresponding to intermedi-
ate (320–340 nm) and low (310–321 nm) polarity, accounted
Table 1
The parameters of the log-normal Gaussian components of the steady-state fluorescence emission spectra of TM17 and mTM17 in detergent micelles and pure solvents
Sample log-normal Gaussian #1 log-normal Gaussian #2 log-normal Gaussian #3
λmax (nm) FWHM
(cm–1)
Spectrum peak
height (%)
λmax (nm) FWHM (cm
−1) Spectrum peak
height (%)
λmax (nm) FWHM
(cm−1)
Spectrum peak
height (%)
TM17 in DPC 347 3862 44 314 3293 47 302 754 9
TM17 in DM 349 3897 43 319 3396 49 303 745 8
TM17 in DMSO 339 4953 94 – – – 305 2127 6
mTM17 in DPC 351 3817 18 331 5042 76 303 814 6
mTM17 in DM 354 4057 33 324 4158 59 303 761 8
mTM17 in MetOH 337 5214 97 – – – 304 1238 3
The decomposition procedure is detailed in Materials and methods. λmax is calculated as 1/νm×10
4 and the spectrum peak height as Imi/ΣImi. FWHM is the full width
at half maximum.
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and widths (except for P13). The major change from P3 to P13 is
a significant blue-shift (by 10 to 20 nm) for both components.
The previously studied raw spectra of Pn in DM were analyzed
similarly: similar trends were observed but the lower wavelength
component was blue-shifted by a few nm (to 304–314 nm) with
respect to that in DPC and the components were significantly
narrower.
The most straightforward interpretation of these data is that
occurrence of transverse diffusion of the model peptides around
a mean location in the mixed peptide-detergent micelles
accounts for this apparent heterogeneity.
3.3. Steady-state fluorescence quenching of TM17 and mTM17
by brominated detergents
We have previously shown, using the set of Pn model
peptides, that Trp quenching in DM micelles by its brominated
analogs (BrDM and BrUM) was dependent upon Trp depth in
the micelle [17]. Quenching by these dibrominated analogs of
DM was highly efficient so that ∼95% quenching wasFig. 3. Fluorescence emission spectra of the Pn model peptides in DPC micelles.
Normalized emission spectra of P3 (solid line and hatched area), P5 (medium
dashed line), P7 (short dashed line), P9 (dotted line), P11 (dashed-dotted line)
and P13 (dashed-double dotted line), (8 μM) in 10 mM potassium phosphate
buffer, pH 7.5, supplemented with 4 mM DPC, at 20 °C. λex was set at 278 nm.
Slit widths were 1.25 mm (bandwidths∼ 5 nm) for both excitation and emission.
Spectra were recorded after a short period of equilibration (2–3 min). The
vertical dashed line indicates λmax for P3.experimentally determined for these model peptides as well as
for TOE [21] and for fragments of PMP1 [41], a single span
membrane protein, when solubilized in pure brominated
detergent micelles.
Fig. 4A shows the fluorescence quenching curves of TM17
and mTM17 in mixed micelles of DM with BrDM, plotted as a
function of BrDM molar ratio. The curves were fitted as
previously described (see legend to Fig. 4), yielding two
parameters: the lattice parameter n, characteristic of the
curvature, and the residual fluorescence of the peptide in the
presence of pure brominated detergent micelles (i.e. at X
(BrDM) =1), Fmin/F0. The inset shows the calibration graph of
n previously obtained with the whole set of Pn model peptides
and the horizontal lines corresponding to the n values for TM17
and mTM17. Panel B shows the results of similar experiments
with BrUM rather than BrDM.
Both TM17 and mTM17 were significantly quenched in pure
BrDM micelles (panel A), as shown by the low residual
fluorescence Fmin/F0 (∼20%), an unambiguous indication that a
major fraction of the Trp in these peptides was in close contact
with the detergent acyl chain. However, this level of residual
fluorescence is higher than the values obtained for the model
peptides (Fmin/F0∼ 5%). The shape of the curve is determined by
the parameter n. The n values obtained with BrDM reflect the
accessibility of Trp to the middle of the detergent acyl chain—
the C7 to C8 carbons to which the two bromine atoms are bound.
The calibration curve of n in BrDM (inset) shows that n is a
complex function of Trp position in the micelle. The quenching
curve for mTM17 is positioned slightly higher on the axes than
that for TM17, and the values obtained with mTM17 and TM17
(n=2.0 and 2.2, respectively) are slightly or significantly below
those of the calibration curve, indicating lower Trp accessibility
for these two peptides than for the model peptides.
Similar trends were observed in BrUM (Fig. 4B). With this
detergent, we tested the accessibility of Trp to the end of the
detergent acyl chain (C10 and C11 carbons), to which the two
bromine atoms are bound. Fmin/F0 values were higher (20–
28%) for mTM17 and TM17 than for the model peptides (∼ 8%
as a mean in this detergent). The n values for mTM17 and
TM17 (respectively 2.9 and 3.2) were significantly higher than
those in BrDM – as reported for the model peptides – but the
values obtained were significantly lower than the values
obtained for any of the model peptides (inset to panel B).
Table 2
Parameters of the log-normal Gaussian components of the steady-state fluorescence emission spectra of model peptides P3 to P13 in DPC and DM
Sample Raw spectrum log-normal Gaussian #1 log-normal Gaussian #2
λmax (nm) λmax (nm) FWHM (cm
−1) Spectrum peak
height (%)
λmax (nm) FWHM (cm
−1) Spectrum peak
height (%)
P3 in DPC 329 339 4501 49 320 4005 51
P5 in DPC 330 340 4639 47 321 4108 53
P7 in DPC 328 334 4760 43 321 4541 57
P9 in DPC 322 334 4562 46 310 3845 54
P11 in DPC 316 328 5071 48 310 4377 52
P13 in DPC 314 320 7618 43 311 3963 57
P3 in DM 327 a 339 3666 50 314 2765 50
P5 in DM 326 336 4216 61 311 2931 39
P7 in DM 327 335 3916 59 311 2667 41
P9 in DM 321 328 4056 59 304 2898 41
P11 in DM 317 328 4034 58 304 2615 42
P13 in DM 313 327 3854 54 304 2379 46
The decomposition procedure is detailed in Materials and methods. λmax is calculated as 1/νm×10
4 and the spectrum peak height as Imi/ΣImi. FWHM is the full width
at half maximum.
a λmax for Pn in DM are from [17].
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micelles, but also show that they are not inserted into these
micelles in the same way as the model peptides: a slightly higher
proportion of Trp is out of reach of bromine atoms and the
cooperativity for quenching is lower. In addition, the Trp in
mTM17 appears to be slightly less accessible to detergent acyl
chains than that in TM17. A plausible explanation for these data,
in agreement with emission spectral data, is that Trp may be
located closer to the surface of the micelle for TM17 and mTM17
than for any of the model peptides, possibly due to an interfacial
location of the fragments in the micelle. However, at this step, we
cannot exclude the fact that the presence of some oligomers may
also contribute to Trp shielding from bromine atoms.
3.4. Acrylamide quenching of TM17 and mTM17 in DM and
DPC micelles. Comparison with model peptides
If Trp in TM17 or mTM17 was less accessible to detergent
chains than in model peptides, it can be expected to be more
accessible to water-soluble quenchers. We therefore assessed its
accessibility to acrylamide, a neutral, water-soluble quenching
probe. Acrylamidewas chosen in preference to iodide to avoid the
specific charge effects previously shown to occur with DPC [32].
The Stern–Volmer plots of fluorescence quenching obtained
for TM17 and mTM17 in the presence of DM or DPC micelles
are shown in Fig. 5. For both peptides, linear fits were adequate,
typical of a simple collisional (dynamic) mechanism. The
apparent accessibility to acrylamide (Fig. 5 and Ksv in Table 3)
was one half to one quarter that of NATA in buffer, taken as a
reference. A comparison of the bimolecular quenching
constants kq (see Table 3) indicated similarly restricted
accessibility (of ∼35%) of TM17 to acrylamide in both DM
and DPC, whereas mTM17 appeared to be more accessible in
both detergents (∼65%).
For comparison, representative Stern–Volmer plots of quen-
ching for Pnmodel peptides in DPCmicelles are shown in Fig. 6.
The apparent accessibility of Trp to acrylamide decreases from
P3 to P13, reaching very small values. Quenching parameters aregiven in Table 3 and accessibilities with respect to NATA ranged
from 34 to 13%, consistent with Trp being located in the
hydrophobic core of the micelle, at various distances from the
center.
Trp in TM17 or mTM17 appears to be more accessible to
acrylamide than in any of the model peptides. This observation
again highlights the particular properties of both MRP1
fragments.
The fraction of fluorescence quenched by acrylamide
exceeded the fraction not quenched by brominated detergents
(Fmin/F0). This suggests that some Trp may be accessible to
both acrylamide and brominated detergent chains. We assessed
the extent to which quenching by acrylamide and quenching by
brominated detergents were complementary, by measuring
quenching by 0.2 M (final concentration) acrylamide for
TM17 and mTM17, in the presence of pure brominated
detergent, BrDM or BrUM, in the experimental conditions
used for the Stern–Volmer plots (λexc=295 nm). In these
conditions, the quenching by pure brominated detergent (4 mM
in buffer) of the Trp in TM17 and mTM17 was similar to that for
excitation at 280 nm, resulting in 18 to 28% residual
fluorescence with respect to peptide in DM. In all cases, the
residual fluorescence was further reduced to 10 to 12% in the
presence of brominated detergent and 0. 2 M acrylamide. Thus,
Trp can be quenched by acrylamide or brominated detergent,
and in some cases, by both. These data seems to discard the
possibility of significant oligomerization of the peptides.
3.5. Time-resolved fluorescence intensity measurements for
MRP1 fragments in solvents, DM and DPC
Trp fluorescence lifetime distributions are sensitive indica-
tors of ground state heterogeneity (such as conformer distribu-
tion [43–47]) and reactions implying the excited-state (energy
transfers, dipolar relaxation [48]).
In neat solvents (DMSO for both peptides and MeOH for
mTM17), the analysis of the fluorescence decays showed one
major population with a long lifetime indicating one major
Fig. 5. Stern–Volmer plots of acrylamide quenching of TM17 and mTM17 in
DPC and DM micelles. 8 μM TM17 (closed symbols) or mTM17 (open
symbols) was added to 10 mM phosphate buffer pH 7.5, at 20 °C, supplemented
with 4 mM DPC (circles) or DM (squares). Aliquots of acrylamide were then
added sequentially, at 100 s intervals. Fluorescence intensity was continuously
recorded with λex set at 295 nm and λem set at 340 nm. Bandwidths were
1.25 mm for excitation and 2.5 mm for emission. The fluorescence intensities
obtained at each acrylamide concentration were corrected for blank values. For
comparison, a similar experiment was also performed with NATA (5 μM) in
buffer (open circles) (λem=354 nm in this case). A straight line was fitted to the
data for both peptides in the presence of detergent, whereas the modified Stern–
Volmer equation was used for NATA.
Table 3
Parameters of TM17, mTM17 and of transmembrane model peptides Pn
fluorescence quenching by acrylamide
Sample Medium <τ> (ns) Ksv (M
−1) kq (M
−1 s−1)
(% of reference)
NATA Buffer 3.0 17.5 5.8×109 (100%)
TM17 DM micelles 2.1 4.07 1.9×109 (33%)
TM17 DPC micelles 2.9 6.79 2.3×109 (39%)
mTM17 DM micelles 2.0 8.86 4.4×109 (75%)
mTM17 DPC micelles 2.9 9.63 3.3×109 (57%)
P3 DPC micelles 4.6 6.86 1.5×109 (26%)
P7 DPC micelles 3.0 5.81 2.0×109 (34%)
P9 DPC micelles 2.7 3.75 1.4×109 (24%)
P13 DPC micelles 2.9 2.14 0.74×109 (13%)
The mean lifetime was <τ>=Σαiτi. For NATA, the mean lifetime was taken from
[89]. For peptides,<τ>values were taken from Table 4, except for mTM17 (the
value of TM17 in DPC was taken). Ksv were the slopes from Figs. 5 and 6.
kq=Ksv/<τ>.
Fig. 4. Quenching curves of TM17 and mTM17 fluorescence in mixed micelles
of BrDM/DM or BrUM/DM. (A) TM17 (closed symbols) or mTM17 (open
symbols) (5 μM) was added to 10 mM potassium phosphate buffer pH 7.5
supplemented with a mixture of BrDM and DM, at a final total detergent
concentration of 4 mM, at 20 °C. The resulting fluorescence intensity was
recorded for 200 s, to allow similar equilibration, and the final fluorescence
intensity was corrected for the blank value (detergents in buffer) and plotted as a
function of the molar fraction of brominated detergent X, defined as X=
[BrDM]/ ([BrDM]+[DM]). X was varied between 0 (pure DM micelles) and 1
(pure BrDMmicelles). λex was set at 280 nm and λem at 335 nm, with slit widths
of 1.25 mm for both excitation and emission. Data points are the means of
duplicate measurements. The function F/F0=(1−Fmin /F0)(1−X)n+Fmin /F0
was fitted to the data (see Materials and methods). The inset shows the
calibration curve of n for BrDM obtained with six Pn model peptides
(continuous line, closed symbols), where n is plotted as a function of Trp
position in the peptide [17]. The two horizontal lines represent the n values
obtained here for TM17 (long dash) and mTM17 (short dash). (B) As above, but
with BrUM instead of BrDM. Here, each data point is the mean for two
independent experiments. Inset: n values are also shown on the calibration plot
for BrUM obtained with the Pn model peptides (continuous line, open symbols).
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dielectric constant of DMSO favors one Trp ground-state
conformer [49] whereas the whole peptide is likely unfolded
[50]. MeOH also favors one conformer with a similar lifetime as
in DMSO but in a α-helical global structure. In contrast, in
detergent micelles, lifetime distributions are more complex for
both peptides. We observed three principal lifetime populations
for TM17 in DPC (Fig. 7B) and four in DM (Table 4). mTM17showed also four lifetime populations in DM. This indicates a
more heterogeneous conformer distribution in micelles as
compared to the solvents. The similarity of the lifetime
distribution profiles for mTM17 and TM17 in DM micelles
shows that the presence of the N-terminal charged residue (K)
has little effect on the Trp conformer distribution and their close
environment, at least in this detergent.
3.6. Time-resolved fluorescence anisotropy measurements of
MRP1 fragments in solvents, DM and DPC
Anisotropy measurements were performed in order to
characterize the rotational dynamics of the systems under
Fig. 6. Representative Stern–Volmer plots of acrylamide quenching of Pn model
peptides in DPC micelles. Pn model peptides (5 μM) were added to 10 mM
phosphate buffer pH 7.5, supplemented with 4 mM DPC, at 20 °C. Aliquots of
acrylamide were then added sequentially, at 100 s intervals. Fluorescence
intensity was continuously recorded with λex set at 295 nm and λem at 340 nm
for P3 and P7 and 320 nm for P9 and P13 (slightly above and below their λmax
values, respectively, to avoid the Raman peak maximum close to 330 nm in
these conditions). Bandwidths were 1.25 mm for excitation and 2.5 mm for
emission. The fluorescence intensities obtained at each acrylamide concentra-
tion were corrected for blank values. The plot for NATA in buffer alone is shown
for comparison (open circles). A straight line was fitted to the data for the
peptides in the presence of DPC.
Fig. 7. MEM recovered lifetime distributions of TM17 in DMSO or DPC
micelles. (A) TM17 was used at a concentration of 10 μM in DMSO. λex=
295 nm, λem=338 nm, excitation and emission bandwidths: 4 and 8 nm,
respectively. The normalized area αi and barycenters τi of each peak of the
lifetime distribution were as follows: α1=0.01, α2=0.13, α3=0.86; τ1=0.33 ns,
τ2=2. 5 ns, τ3=6. 9 ns; χ
2=1.03. (B) TM17 was used at a concentration of
5 μM in 10 mM phosphate buffer (pH 7.5) containing 4 mMDPC. λex=292 nm,
λem=332 nm, bandwidths as above. α1=0.23, α2=0.38, α3=0.38; τ1=0.48 ns,
τ2=1. 7 ns, τ3=5. 4 ns. χ
2=1.05. The temperature was constant at 20 °C in all
cases.
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distributions, obtained from MEM analysis of polarized
fluorescence decays, are shown in Table 5. In neat solvents,
we observed for both peptides a single rotational correlation
time (θ3) in the nanosecond range representing their Brownian
motions. Its values for both peptides are consistent with a
monomer in DMSO or a dimer in MeOH, taking into account
the viscosity of the solvents (η20°C=2.1 cP and 0.6 cP for
DMSO and MeOH respectively). Subnanosecond rotational
correlation times are also observed (Table 5), describing the fast
local motion of the Trp side-chain around the Cα–Cβ–Cγ
bonds. Using the wobbling-in-cone model for this motion [51],
we estimated the cone semi-angle ωmax to be 45–50°.
In DM and DPC micelles, the values of the Brownian
rotational correlation times are increased by about one order
of magnitude with respect to that in neat solvents, reflecting
the incorporation of the peptides into detergent micelles
(Table 5). In DM, the mixed peptide–detergent micelles have
approximately the same rotational correlation time (and
therefore the same size) than pure DM micelles (theoretical
value: 21 ns, without taking into account micelle hydration,
see Materials and methods). In DPC, the mixed micelles
could be larger than pure DPC micelles (theoretical value of
7.4 ns). In both detergents, a second nanosecond rotational
correlation time, 10–20 times shorter than that for Brownian
dynamics, describes the local motions of Trp and/or the
segmental motion of TM17, which becomes strongly slowed
down as compared to the neat solvent. This component
displayed a larger contribution to the anisotropy in DPC than
in DM (as seen from the β2 values), suggesting a larger localflexibility of the peptide in the former than in the latter detergent.
A third subnanosecond component of small amplitude is
detected in DPC and is likely present in DM since the initial
anisotropy value At = 0 is smaller than the intrinsic anisotropy A0
of Trp [52] measured in glass medium. The wobbling-in-cone
motion – which takes into account all subnanosecond motions,
even those not resolved in the decay – was significantly more
restricted in both detergents than in the solvents, as shown by the
(ωmax) values obtained (Table 5). In DM, mTM17 displays a
wobbling-in-cone motion of larger amplitude than that for
TM17.
3.7. Time-resolved fluorescence intensity measurements of
model peptides P3 to P13 in DPC
The time-resolved fluorescence parameters of the single-Trp
containing Pn model peptides previously measured in DM [17],
were also analyzed in DPC, to provide a reference for
transmembrane peptides incorporated in these micelles. The
results are shown in Table 6. For all Pn peptides, fluorescence
intensity decays were represented by three lifetime populations.
The main trend in variation from P3 to P11 (P13 behaved in an
unusual manner) was a significant decrease in the relative am-
Table 4
Parameters of the fluorescence intensity decays of TM17 and mTM17 in various media
Peptide Solvent α1 α2 α3 α4 τ1 (ns) τ2 (ns) τ3 (ns) τ4 (ns) <τ> (ns) χ
2
TM17 DMSO 0.01 0.13 0.86 0.33 2.5 6.9 6.3 1.03
DM 0.27 0.33 0.28 0.12 0.3 1.2 3.0 6.8 2.1
micelles (±0.07) (±0.04) (±0.03) (±0.07) (±0.1) (±0.2) (±0.7) (±1.3) (±0.2)
DPC 0.22 0.37 0.41 0.4 1.6 5.3 2.9
Micelles (±0.05) (±0.02) (±0.07) (±0.2) (±0.4) (±0.3) (±0.2)
mTM17 DMSO 0.13 0.87 3.0 7.0 6.5 1.06
Methanol 0.20 0.80 1.6 4.9 4.3 1.08
DM 0.21 0.44 0.20 0.17 0.13 1.2 3.2 6.4 2.0
Micelles (±0.02) (±0.08) (±0.02) (±0.04) (±0.02) (±0.1) (±0.2) (±0.2) (±0.3)
Experimental conditions were as for Fig. 7 for TM17. A different experimental setup was used for the experiments with mTM17: the source was a LED (light-emitting
diode) with maximal emission at 298 nm. mTM17 was used at a concentration of 30 μM in methanol and in DMSO, with λex=295 nm, λem=337 nm, 16 nm slits for
both excitation and emission and a cutoff filter (T50% at 306 nm) on the emission pathway. In DM, mTM17 was used at a concentration of 15 μM. αi is the normalized
area and τi the barycenter of each peak i of the lifetime distribution obtained in MEM analysis. The mean lifetime <τ> is calculated as <τ>=Σαiτi. Either representative
data (with χ2 values) or mean values (±standard error) over 2–3 experiments are given.
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nanosecond lifetimes (τ2 and τ3). As a result, the mean
lifetime <τ> halved between P3 and P11 like in DM [17].
Higher <τ> values than in DM (up to 30% for P9) were however
observed in DPC (in DM, the distribution also displayed a minor
contribution of a fourth, very short component). These higher
<τ> values mainly result from a higher contribution of the
longest lifetime population (i.e. α3) in DPC than in DM. They
likely reflect differences in the local conformer equilibrium of
the Trp residue [45,53] under the influence of the different polar
headgroups of the detergent (sugar and choline for DM and
DPC, respectively) on the packing and/or dynamics of the whole
micelle.
3.8. Time-resolved fluorescence anisotropy measurements for
model peptides P3 to P13 in DPC
Table 7 shows the parameters of the anisotropy decays of Trp
in the model peptides in interaction with DPC micelles. The
rotational correlation time distribution showed subnanosecond
and nanosecond rotational motions. The mean value of the
major long rotational correlation time over the six peptides wasTable 5
Parameters of the fluorescence anisotropy decays of MRP1 fragments in various me
Peptide Solvent β1 β2 β3 θ
TM17 DMSOc 0.127 0.009 0.092 0
DMb 0.016 0.123
micelles (±0.006) (±0.012)
DPCb 0.016 0.042 0.096 0
micelles (±0.019) (±0.011) (±0.004) (±
mTM17 Methanola 0.158 0.071
DMSOa 0.113 0.069
DMa 0.133
Micelles (±0.023)
Experimental conditions were as described in Table 4. The anisotropy βi is the area a
correlation time distribution. At = 0 is the anisotropy at time zero, with At = 0=Σβi. The
from: Σβns/A0= [1/2cosωmax(1+cosωmax)]
2, which gives: ωmax=Arccos1/2[(1+8(Σβ
βns the anisotropies of the nanosecond components. Values of 0.251, 0.240 and 0.154
295(c) nm, respectively. The A0 value of 0.251 was calculated from the wavelength con
NATA (from [52]). Representative data (with χ2 values) or mean values (± s.d.) arein the range of 17 ns (±6 ns). This is significantly shorter than
the mean value previously obtained for Pn-DM mixed micelles
(36±5 ns), consistent with a smaller size of the Pn-DPC mixed
micelles. The shorter components reflect the local mobility of
Trp with respect to the micelle. The local subnanosecond
motion was characterized by a mean “wobbling-in-cone” angle
close to 32° (±4°)—similar to that previously measured in DM
(30° ± 3°). The value of the rotational angle increased from P3
to P13 by 30% (Table 7), suggesting that the local constraints to
the Trp rotation are stronger near the water/micelle interface
than in the center of the DPC micelle.
3.9. CD spectra of mTM17 in various media
The secondary structure of mTM17 was assessed by circular
dichroism (Fig. 8A). In all conditions, the four successive scans
registered for each spectrum were superimposable. The
spectrum for mTM17 in methanol, as a reference, had an
overall shape characteristic of an α-helix signal, with a strong
positive maximum at 191 to 192 nm and two negative minima at
208 and ∼220 nm. The α-helix content was estimated at 77%
from the value of [θ]222nm [38]. Note that the [θ]191/[θ]208 ratio,dia
1 (ns) θ2 (ns) θ3 (ns) At = 0 ωmax (°) χ
2
.34 0.55 2.9 0.228 45 1.09
1.4 28 0.139 17
(±0.5) (±5) (±0.013) (±3)
.50 2.4 22 0.154 17
0.04) (±0.6) (±3) (±0.011) (±9)
0.14 1.5 0.229 50 1.07
0.21 2.0 0.182 50 1.03
16 0.133 37
(±1) (±0.023) (±5)
nd the rotational correlation time θi is the barycenter of peak i of the rotational
semi-angle ωmax of the wobbling-in-cone subnanosecond motion was calculated
ns/A0)
1/2)1/2−1], where A0 is Trp anisotropy in the absence of depolarization and
were taken for excitation with the PLS295(a) and with the synchrotron at 292(b) or
volution of the nanoLED optical power emission with the intrinsic anisotropy of
given.
Table 6
Parameters of the fluorescence intensity decays of model peptides P3 to P13 in
DPC micelles
Peptide Solvent α1 α2 α3 τ1 (ns) τ2 (ns) τ3 (ns) <τ> (ns) χ
2
P3 DPC 0.11 0.18 0.71 0.6 2.9 5.7 4.6 1.07
P5 – 0.16 0.26 0.58 0.7 2.7 5.9 4.3 1.03
P7 – 0.23 0.34 0.43 0.6 2.3 4.8 3.0 1.03
P9 – 0.28 0.41 0.31 0.6 2.1 5.3 2.7 1.05
P11 – 0.38 0.25 0.37 0.5 2.2 4.6 2.3 1.03
P13 – 0.13 0.23 0.64 0.3 0.9 4.1 2.9 1.15
Pn peptides were used at a concentration of 10 μM in 25 mM potassium
phosphate buffer pH 7.5 supplemented with 4 mM DPC, at 20 °C. λex=280 nm
λem=327 nm (for P3, P5, P7), 321 nm (for P9), 316 nm (for P11) and 312 nm
(for P13), as in our previous experiments in DM.
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characteristic of an α-helix. Absolute ellipticities were com-
paratively low for mTM17 in buffer, with significant differences
in the shape of the spectrum (a weak positive peak at ∼190 nm
and a single minimum at ∼215–217 nm). DPC had a strong
helix-promoting effect on this peptide, as compared to buffer
alone, resulting in an α-helix content of about 50%, as
calculated from [θ]222nm. DM had the same overall effect but
with a slightly less efficiency than DPC.
We made this analysis more specific, with the aim of
identifying the other secondary structure components, by
deconvoluting the CD spectra with two programs and the
same two sets of reference proteins with each program, which
should improve the reliability of predicted structures [39,40].
The fractions of α-helix, β-sheets, turns and unordered
structures are presented as histograms in Fig. 8B. The four
analyses gave consistent results so that the contribution of the
main structural elements could be reliably estimated. In
detergent, the main fraction of α-helix accounted for about
45% of the peptide, with unordered structures accounting for
about 25% of the peptide. In buffer, β-strands made a
significant contribution to secondary structure.
As the N-terminal mutation is unlikely to change the
structural propensity of the peptide, and the lack of a charged
residue may result in the N-terminus being inserted more deeply
into the micelles, TM17 would be expected to contain at least as
much α-helix in micelles. However, as DMSO absorbs strongly
in the spectral region used for CD experiments, we could not
monitor TM17 spectra in similar conditions.Table 7
Parameters of the fluorescence anisotropy decays of model peptides P3 to P13 in
DPC micelles
Peptide β1 β2 β3 θ1
(ns)
θ2
(ns)
θ3
(ns)
At = 0 ωmax
(°)
χ2
P3 – 0.020 0.103 – 1.1 14 0.123 27 1.02
P5 0.017 0.038 0.079 0.6 3.0 17 0.134 29 1.00
P7 – 0.033 0.094 – 1.4 14 0.127 26 0.97
P9 0.029 0.039 0.060 0.4 4.1 15 0.128 34 1.02
P11 0.068 0.026 0.063 0.1 1.7 12 0.143 37 1.02
P13 0.010 0.018 0.063 0.5 2.0 30 0.126 39 1.01
Conditions were as in Table 6. The excitation wavelength was 280 nm; A0 was
therefore taken as 0.173 [52].3.10. Steady-state fluorescence spectra of TM17 and mTM17 in
phospholipid vesicles
The behavior of each peptide in the presence of membrane
vesicles was studied for the sake of comparison with the micellar
systems. Steady-state fluorescence spectra were performed on two
types of samples. They were prepared either by addition of the
peptide (5μM) to a dispersion of sonicatedmembrane vesicles (egg
PC alone or a egg PC/PS 1/1 (mol/mol) mixture, lipid/peptide
molar ratio of∼ 100) or co-evaporation of a chloroformic solution
of peptide and phospholipids and dispersion in buffer by sonication.
The fluorescence emission intensity of each peptide in the absence
of lipid vesicles was maximum at∼ 335–336 nm and decreased as
a function of time, indicating a time-dependent auto-association. In
the presence of either PC or PC/PS vesicles, the maximum slightly
shifted to 331–332 nm in both types of preparations (not shown),
close to the values in detergent micelles.
4. Discussion
This study focused on the interaction with membrane mimics
of TM17, a functionally important predicted TM fragment ofFig. 8. Far UV CD spectra of mTM17 in various media. (A) Data are represented
as molar ellipticity per residue. Spectra were registered with 100 μMmTM17 in
methanol (continuous black line) or 25 μMmTM17 in buffer alone (dashed line)
or in the presence of 4 mM DPC (red line) or DM (blue line). Further details are
provided in Materials and methods. (B) Histograms for the various structural
elements (H: helix, S: β-strands, T: turns, U: unordered structures).
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[54]. This model was not straightforward to establish since
various plausible predictions have been successively proposed.
It takes into account, in addition to classical hydropathy analysis,
experimental determination of extra-cellular N-glycosylation
sites, the orientation of various loops by epitope insertion and
immunofluorescence, as well as comparison with similar
proteins. In the absence of 3-D structure, validation of the
model is not yet possible. MRP1 is rich in Trp residues, with 30
in total, 12 of which are located within or very close to predicted
TM segments. Trp is heterogeneously distributed among these
TM segments, which may have between zero (e.g. TM11 to
TM15) and three Trp (TM2) residues. This distribution is
probably not purely fortuitous. Due to their specific properties,
including H-bonding ability, and cation-π effects [55,56],
membrane protein Trp were shown to be preferentially located
at interfacial regions of the membrane (e.g. [57]) where theymay
have several functions, including TM anchorage in the
membrane, protein stabilization and substrate binding. TM17
contains a single Trp (W1246) residue, making it possible to use
this fragment to investigate the local structure, dynamics and
location of the peptide in membrane mimics by fluorescence
spectroscopy. W1246 is thought to be involved in substrate
binding and the substrate translocation pathway [2,11]. Its
position in the sequence, close to the cytoplasmic C-terminus of
TM17, also suggests a possible role in anchoring TM17 in the
membrane. We studied a synthetic TM17 fragment encompass-
ing the predicted TM17 fragment and slightly extended at the C-
term, so as to include the functionally important Arg1249. We
studied in addition a synthetic mutant, mTM17, bearing an
additional positive charge in the N-term. Peptide secondary
structure elements were also characterized under the same
conditions by CD spectroscopy.
As previously described , we used DM and DPC micelles as
membrane mimics. DM is one of the most suitable detergents
for the solubilization, purification and stabilization of activity
of a wide range of membrane proteins including MRP1 (see
[58–60] for comparative studies with numerous detergents;
[15,61–63] for recent purifications of overexpressed proteins).
DM has also been used to crystallize some of the few
membrane proteins for which X-ray structures have been
resolved [64,65]. We previously made synthesize brominated
analogs of this detergent for topological studies by fluores-
cence spectroscopy [20,21], which were used in the present
work. These detergents could also be visualized by X-ray
diffraction in membrane protein crystals, due to their high
electron density ([66–68] and ref. therein). DPC is the
detergent of choice in NMR experiments, as its micelles are
small, like those of SDS, but, beyond this technical reason
which is not so stringent for fluorescence, above all DPC very
efficiently reproduces the interfacial region of phospholipid
bilayers with water, with a similar head group as phosphati-
dylcholine [25]. It is used more specifically for structural
studies of amphiphilic peptides [69–72], membrane protein
fragments [73,74] and small proteins (e.g. [75]).
TM17 and mTM17, studied at micromolar concentrations
sufficient for fluorescence and CD experiments, were bothreadily solubilized in the presence of excess detergent micelles.
This is shown for instance by the strong fluorescence quenching
(up to ∼ 80%) of these fragments in mixed micelles of DM and
one of its brominated analog, BrDM or BrUM, because this
quenching requires close contact between Trp and the bromine
atoms, located on the detergent acyl chain. In addition, the
significant accessibility of Trp to acrylamide seems to rule out
the presence of oligomers, since no Trp seems to be shielded
from both quenchers. Further evidence is provided (i) by the
structuring effect of the detergent, (ii) by rotational correlation
time measurements –which reflect the whole peptide–detergent
complex rotation – and (iii) by the more stable fluorescence
intensity than observed for peptide in buffer alone.
The maximum wavelength of Trp fluorescence emission,
λmax, is very sensitive to the polarity – or local electric field – of
the Trp environment (e.g. [76] and ref. therein), with red-shifts
observed as polarity increases. In proteins, λmax may vary from
308 nm (for a completely buried Trp residue) to 355 nm (for a
Trp residue fully exposed to water) [34]. Using Pn transmem-
brane model peptides in DM [17] or DPC (present study)
micelles, we have shown that the λmax of the raw spectra for Pn
ranges from 314 nm, for a Trp residue located in the core of the
micelle, to 327–330 nm, for a Trp residue located close to the
polar headgroup region. In the present study, each of these
spectra was further decomposed into two log-normal Gaussian
components, for which λmax ranged from 304 to 340 nm,
reflecting the wide range of polarity (or local electric field)
experienced by Trp residues within these micelles. This data
analysis indicated significant fluctuations in peptide positions,
without significant contact between Trp and the bulk solvent.
These results are consistent with molecular dynamics simula-
tions, indicating fast dynamics, in the nanosecond time range, of
detergent molecules in DPC micelles [77,78] and bound
peptides in mixed micelles [79].
The raw emission spectra of the MRP1 fragments, TM17 and
mTM17, interacting with detergent micelles, were characterized
by a λmax at 332–335 nm, corresponding to a Trp environment
more polar than that experienced by the Pn model peptides. The
analysis of these emission spectra using log-normal Gaussian
components also suggested that the Trp environment was
heterogeneous, with a major low-polarity component (∼ 50–
80%) and a component with higher polarity, close to that of an
aqueous environment. This polar environment does not
correspond to any of the environments experienced by the Pn
model peptides. Thus, several positions and/or conformations
within the micelle can be inferred for TM17 and mTM17, some
of them not being observed for the model peptides.
The maximal quenching value of TM17 or mTM17 obtained
in the presence of pure brominated detergent micelles (70–80%)
is consistent with the contribution of the more hydrophobic
component of the spectra. This component of the spectra may
therefore be attributed to Trp into contact with the detergent acyl
chain. However, the shape of the quenching curves (character-
ized by the lattice parameter n, reflecting quenching coopera-
tivity) show that the Trp in TM17 or mTM17 is less accessible
to detergent bromine atoms than that in Pn model peptides.
Surprisingly, Trp was also clearly accessible to acrylamide (as
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adding the fraction of Trp accessible to acrylamide to that
accessible to (brominated) acyl chains yielded more than 100%.
These data may be interpreted as some Trp being accessible to
both detergent chains and acrylamide. Detergent chains may
fold back, so some quenching may occur within or close to the
polar headgroup region. In addition, acrylamide accessibility is
clearly not limited to a smooth surface around the micelle,
because acrylamide somehow penetrates into the polar head-
group region, the extent of this penetration being smaller in DM
than in DPC as judged from TOE fluorescence quenching in
these micelles [32]. These results can be compared with those
obtained in a detailed fluorescence study of various Trp mutants
of the mechanosensitive channel MscL in a lipid model
membrane: a clear and (opposite) dependence on Trp depth,
of quenching by either a brominated lipid (di(9,10-dibromos-
tearoyl-phosphatidylcholine)) or acrylamide [80] was observed.
In this previous study, there seemed to be less overlap in
quenching by brominated lipid and acrylamide for the Trp close
to the membrane surface, consistent with more restricted
dynamics of this system.
Time-resolved experiments provide additional clues. The
homogeneity of the lifetime distributions of MRP1 fragments in
neat solvents can be differently rationalized. Methanol is known
as a promoter of peptide α-helix content which results in a
major Trp conformer with a long lifetime. DMSO is more
generally thought to favor a lack of secondary structure by
disruption of intramolecular interactions [50] and may also
specifically interacts with the indole ring, favoring a major
conformer with the same lifetime as in MeOH [49]. In
detergents, the lifetime distributions for MRP1 fragments and
Pn peptides are more heterogeneous than in solvents, reflecting
local conformer heterogeneity and less structure than in
methanol. The lifetime distributions in the two detergents are
also significantly different, being more heterogeneous in DM
than in DPC. In particular, the amplitude of the longest lifetime,
which is sensitive to the presence of α-helical structure [46], is
reduced in DM as compared to DPC. This evidences a larger
structural heterogeneity in the former than in the latter system.
Moreover, the lifetime distributions of these MRP1 fragments
do not exactly match any of those of model peptides. A
significant trend was a smaller contribution of the longest
lifetimes for MRP1 fragments with respect to model peptides, to
the benefit of the intermediate lifetimes. This may indicate a less
probable inclusion of Trp in an α-helix structure [46].
Significant nanosecond internal motion of the fragments within
micelles was also evidenced, in particular in DPC, so that a
same Trp may exhibit various degrees of accessibility to the
water-soluble and micelle-bound quenchers during its lifetime.
This situation may occur if the peptide inserts parallel to the
micelle surface in the polar headgroup region and rotates on
itself.
Such interfacial location is consistent with the results
obtained in phospholipid vesicles, in particular the slight blue-
shift of the emission spectrum with respect to that for the
peptide in buffer. Time-resolved measurements in the presence
of phospholipid vesicles were also performed (not shown) butwhere less reliable than in the optically clear micelles owing to
the larger scattering of the liposomes.
Information about the overall structure of these fragments is
provided by the CD experiments.Methanol promotes a highlyα-
helical structure (> 75% for mTM17), in agreement with
numerous studies of hydrophobic and amphiphilic peptides. This
high α-helix content matches the large amplitude of the longest
lifetime in the solvents, which corresponds to the major t (trans)
conformer in such secondary structure [46]. In contrast, mTM17
is much less helical in buffer. Interaction with detergent micelles
induces significant structuring of the peptide (up to ∼ 45% α-
helix) as compared to buffer, but structuring remains less marked
than would be expected for a peptide inserted radially within the
micelle. In agreement with the lifetime distribution data, DPC
exerts a stronger structuring effect than DM, as previously
shown with fragments of a single-spanning membrane protein
[41]. Together with the fluorescence data, these results suggest
that the peptide is partly helical and located in the interfacial
region of the micelle. They are also consistent with part of the
sequence being composed of alternate hydrophobic and polar
residues. CD does not indicate which regions of the peptide are
structured, but secondary structure prediction programs (from
www.predictprotein.org [81]) suggest that the structured part of
the molecule lies within the Ser1235–Leu1247 sequence, which
includes the Trp1246 residue at the edge of the helix. The rest of
the peptide, in particular the hydrophobic stretch of 6 amino
acids of the N-terminal fragment, is predicted to have no defined
secondary structure.
Based on convergent results, we propose that the predicted
TM17 fragment of MRP1 in the current topology model may
behave, when isolated, like an amphiphilic peptide, resembling
some antimicrobial peptides, such as those previously described
[82–85] rather than a classical transmembrane segment. TM17
fragment is indeed the most amphipathic of all TM of MRP1
[9,86], and was not detected as a TM fragment in initial topology
models. We suggest here that isolated TM17 mainly interacts
with the interfacial region of the membrane, with no complete
and stable (but maybe transient) insertion in a transmembrane
orientation. The replacement of a neutral terminal residue by a
charged residue (TM17/mTM17) appears to modify the depth of
insertion with respect to the micelle surface slightly, as shown by
the fluorescence quenching experiments. Within MRP1, TM17
might be driven to its transmembrane position by being linked to
the rest of the protein and/or by its interaction with neighboring
transmembrane segments (not necessarily the most proximal in
the sequence). These opposite trends would give some plasticity
to this protein domain that may undergo conformational changes
of potential functional significance. This is in line with recent
results from Ruysschaert et col. [87] providing evidence of TM
segments motions for the whole protein during transport cycle.
In addition, Trp1246 is a good candidate for being responsible of
the overall changes that they observed in fluorescence quench-
ing for reconstituted MRP1 upon binding of GSH alone, or with
substrates and nucleotides. The behavior of TM17 is also
reminiscent of previous observations for the transmembrane M6
fragment of Ca2+-ATPase (SERCA1a), containing critical
residues for calcium binding. The isolated M6 fragment was
551M. Vincent et al. / Biochimica et Biophysica Acta 1768 (2007) 538–552shown not to have a high affinity for the membrane phase and
was only partially structured [22,88]. This unconventional
behavior of transmembrane domains may be the hallmark of
membrane fragments involved in binding and transport. In a next
step, study of the interaction of isolated TM17 with lipid model
systems may strengthen our observations.
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